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Germanium biotite, a natural mineral, is comprised of mainly silicate. This mineral 
showed activities of increase in feed efficiency and non-specific immunostimulation 
in previous studies. The aims of the present study were to evaluate the prophylactic 
effects of germanium biotite against respiratory diseases in calves as a feed 
supplement and investigate the possibilities of the substitution of antibiotics with 
germanium biotite as feed additive. To achieve these purposes, bovine herpesvirus-1 
(BHV-1) and Mannheimia haemolytica serotype A1 were experimentally inoculated 
into the calves. After challenge, germanium biotite showed a lower cumulative 
clinical score (CCS) than the control group. In accordance with these clinical 
results, enhanced clearance of BHV-1, a low infection rate of Mannheimia 
haemolytica serotype A1, tempered superficial lesions, and moderated 
histopathological signs were observed in the germanium biotite group, compared 
with the control group. The results of the present study indicated that germanium 
biotite had prophylactic effects against bovine respiratory disease and could be a 
candidate for a new alternative feed supplement in calves, through its effects as a 
non-specific immune stimulator. 
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INTRODUCTION 
 
The consumption of livestock products has been 
increasing along with increased per capita income. This 
growth in consumption has driven an increase in the 
importance of the safety of different food commodities. 
Antibiotics have been used as feed supplements to 
improve the rate of gain and feed efficiency and to 
prevent infectious diseases (Muhl and Liebert, 2007). 
However, due to concern about antibiotic residues and 
emerging antibiotic resistance (van den Bogaard and 
Stobberingh, 1999), use of antibiotics as feed additives 
has been banned in the European Union (Kamphues, 
1999) and Korea. For this reason, studies seeking for 
substances which can activate the non-specific immune 
ability in place of antibiotics are actively in progress. 
Biotite, a well known feed supplement, is a common 
phyllosilicate mineral containing potassium, magnesium, 
iron, aluminum, and silicate (Sarker et al., 2010; 
Vondruskova et al., 2010). It has been reported that 
immune cells stimulated by silicate were associated with 
the non-specific immunostimulating ability of biotite. 
Fibrogenic silicate (SiO2) activated proinflammatory 
macrophages (Holian et al., 1997), and aluminosilicate 
(Al2SiO5) improved immune-cell differentiation (Jung et 
al., 2010). These previous studies suggested that 
germanium biotite has potential as a new alternative feed 
supplement for non-specific immunostimulators, 
prophylactic agents, and remedial agents. 
Bovine respiratory disease (BRD) is a major 
economic problem in the cattle industry around the world 
due to morbidity, mortality, low feed efficiency, 
prevention costs, and treatment (Fulton, 2009; Irsik et al., 
2006). The disease is caused by not only multi-factorial 
pathogens but also environmental condition, and Bovine 
herpesvirus type 1 (BHV-1) and Mannheimia haemolytica 
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serotype A1 have been described as major etiologic agents 
(Fulton, 2009). Mannheimia haemolytica serotype A1 
causing BRD in young calves has been detected in the 
respiratory tract of healthy cattle. Although the 
microorganism naturally exists as commensal of the 
respiratory tract, it is also considered the major bacterial 
agent of BRD in calves (Rice et al., 2007). As host 
immunity becomes weaker as a result of stress or infection 
with other pathogens, the microorganism may become 
infective and play an important role in BRD, also known 
as shipping fever in calves. BHV-1 is also a major 
etiological agent of BRD along with Mannheimia 
haemolytica serotype A1 (Autio et al., 2007). BHV-1 is 
an  α-herpesvirinae subfamily member that causes 
significant economic problems in the cattle industry (Irsik 
et al., 2006; Fulton, 2009). Following infection with 
BHV-1, the virus could be latent in sensory ganglia and 
reactivated both by stressful environments and 
administration of glucocorticoids. In addition, BHV-1 
depresses cell-mediated immunity in the host by 
repressing expression of major histocompatibility 
complex (MHC) class І that acts in association with CD8+ 
T-cell recognition of infected cells and transporter 
associated with antigen presentation (Jones and 
Chowdhury, 2007). The suppression of the immune 
function renders the host susceptible to secondary 
infection like pneumonic mannheimiosis, thereby causing 
BRD more easily. 
The aims of the present study were to investigate 
characteristics of germanium biotite, known to the non-
specific immune stimulating mineral, about prophylactic 
effect in BRD infected calves. A BHV-1 and Mannheimia 
haemolytica serotype A1 challenge experiment in calves 
was performed to examine the prophylactic effect of 
germanium biotite against BRD. Finally, an aim was to 
explore the possibilities of the substitution of germanium 
biotite for antibiotics as a feed supplement. 
 
MATERIALS AND METHODS 
 
Source of feed supplements: Germanium biotite (under 
solto Bio) provided by Seobong Biobestech (Seoul, 
Korea) was comprised of silicon dioxide (SiO2, 61.90%), 
aluminum dioxide (Al2O3, 23.19%), iron oxide (Fe2O3, 
3.97%), calcium oxide (CaO, less than 2%), magnesium 
oxide (MgO, less than 2%), and titanium oxide (TiO2 less 
than 2%). 
 
Calves and challenge experiment design: Korean native 
calves of three months of age were used for this study. 
The calves were randomized into two groups: the control 
group (n=3), fed with a normal commercial feed without 
any antibiotics; and the germanium biotite group (n=3), 
fed with the commercial feed supplemented with 0.5% 
germanium biotite. The calves of two groups were housed 
in individual rooms and allowed easy access to water and 
feed. Before the challenge, calves were confirmed as 
negative against respiratory pathogens to be challenged. 
After feeding with those fodders for two weeks, the calves 
were challenged with BHV-1 (5.0 × 10
9 PFU) and 
Mannheimia haemolytica serotype A1 (1.0 × 10
10CFU) 
three times at 24 hours intervals. To equalize natural 
infectious condition, all calves were challenged through 
nasal spray. 
Preparation of pathogens: The BHV-1 used was isolated 
from a calf naturally suffering from shipping fever 
(Animal, Plant and Fisheries Quarantine and Inspection 
Agency, QIA; Anyang, Korea). Before challenge, the 
virus was propagated and titrated in MDBK cells (Abril et 
al., 2004). Mannheimia haemolytica serotype A1 used in 
the study was also provided by QIA. The identity of the 
bacterium was confirmed by using multiplex PCR as 
previously described (Alexander et al., 2008). The 
pathogen was grown on a blood agar plate (BAP) in a CO2 
incubator at 37℃ and subcultured in tryptic soy broth 
(TSB; Difco, MD, USA) to obtain a sufficient quantity of 
challenge agent. Before challenge, the cultured bacteria 
were pelleted by centrifugation, washed three times in 
sterile phosphate buffered saline (PBS), and resuspended 
in PBS. The final concentration of approximately 1.0 × 
10
10 CFU was confirmed according to the standard curve 
of CFUs versus optical density (Hanzlicek et al., 2010). 
After each challenge, plate counts were used to confirm 
bacterial concentration. 
 
Clinical monitoring after pathogens challenge: The 
body conditions and clinical signs of calves were recorded 
each 24 hr throughout the experiment period. Rectal 
temperature, degree of nasal discharge, cough frequency 
degree, and respiratory rate were scored using the criteria 
established by Hodgson et al. (1995) (Table 1). The 
measured scores of each calf were accumulatively added 
and considered as cumulative clinical score (CCS). 
 
Table 1: The criteria for the scoring of clinical signs  
Signs Description  Score 
Temperature  38.0-39.5℃ 
39.5-40.0℃ 
40.0-40.5℃ 
40.51-41.0℃ 
41.0℃ > 
0 
1 
2 
3 
4 
Degree of nasal discharge  Absent 
Mild 
Moderate 
Severe 
0 
1 
2 
3 
Cough frequency degree  Absent 
Mild 
Moderate 
0 
1 
2 
Respiratory rate  < 50 
50-60 
60-70 
70-80 
80 > 
0 
1 
2 
3 
4 
These criteria were modified from Hodgson et al. (1995). 
 
Measurement of challenged pathogens clearance: After 
challenge, nasal swab samples were collected after every 
two days and each sample was resuspended in 1 ml PBS 
and diluted in 10 fold serial dilutions up to 10
-4. Aliquots 
(50µl) of each dilution were used for experiment samples. 
Real-time PCR was used in measurement of virus 
clearance. DNA extraction from each sample was 
performed using the Accuprep genomic DNA extraction 
kit (Bioneer, Seoul, Korea) according to the 
manufacturer’s instructions and used template for real-
time PCR.  Primer and probes for quantitative real-time 
TaqMan   PCR,   real-time    PCR    standard    of   BHV-1 
genomes, and condition were developed and validated as 
TaqMan   PCR,   real-time    PCR    standard    of   BHV-1 
genomes, and condition were developed and validated asPak Vet J, 2012, 32(3): 319-324. 
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Table 2: Primers and probes for PCR 
Pathogens Oligonucleotide  Sequences  (5′-3′) Product  size 
BHV-1 BHV-1  (F)
a 
BHV-1 probe
b 
BHV-1 (R)
c 
TGTGGACCTAAACCTCACGGT 
AGGACCGCGAGTTCTTGCCGC 
GTAGTCGAGCAGACCCGTGTC 
97 bp 
Mannheimia haemolytica serotype A1  Lkt 
HP 
 
16s 
(F) 
(R) 
(F) 
(R) 
(F) 
(R) 
GCAGGAGGTGATTATTAAAGTGG 
CAGCAGTTATTGTCATACCTGAAC 
CGAGCAAGCACAATTACATTATGG 
CACCGTCAAATTCCTGTGGATAAC 
GCTAACTCCGTGCCAGCAG 
CGTGGACTACCAGGGTATCTAATC 
206 bp 
 
90 bp 
 
~304 bp 
a Forward primer;
 b 6-Carboxyfluorescein-labeled probe;
 c Reverse primer. 
 
described previously (Abril et al., 2004). Multiplex PCR 
was used in confirmation of bacterial infection using 
specific primers (Table 2). DNA extraction from aliquots 
of sample was performed according to a previous study 
(Suh and Song, 2005). DNA extracts were used for the 
PCR template as previously described (Alexander et al., 
2008). The total isolated bacteria counts were measured 
by CFU counting. Aliquots (50µl) of each sample dilution 
were applied to BAP and incubated at 37℃ for 16 hr. The 
viable counts were determined and expressed as 
CFU/swab. The area under curve (AUC) of bacteria 
counting graph was calculated for confirmation of total 
shedding bacteria throughout the experiment. 
 
Necropsy:  On day 12
th post challenge, all calves were 
humanely euthanized and their lungs were collected. The 
percentages of superficial lesion area were calculated by 
comparison with total lung area. The lungs and trachea 
were collected from calves, and then representative 
samples were placed in 10% formal-saline for 
histopathological examination using standard techniques. 
Microscopic lesion scores were calculated using a 
described scoring system (Opriessnig et al., 2004). For 
viral and bacterial examination, tissue samples 
(approximately 1 g) were homogenized in 9 ml PBS and 
diluted in 10-fold steps up to 10
-4 and then aliquots (50µl) 
of each dilution were used for experiment samples for 
pathogen examination. 
 
Statistical analysis: The data were expressed as mean ± 
standard deviation (SD), and statistical differences 
between the groups were analyzed with student’s t-test; 
whereas, for microscopic lesion scores, a nonparametric 
test (Mann-Whitney U test) was performed using SPSS 
version 17.0 software (SPSS, Chicago, IL, USA). 
Differences were considered significant when probability 
values of P<0.05 were obtained. 
 
RESULTS 
 
Clinical signs after challenge in experiment calves: The 
CCSs of all calves were 0 before challenge. The CCSs, 
however, appeared to increase after challenge and lower 
CCSs than those of the control group were observed in the 
germanium biotite group throughout the experimental 
period (Fig. 1). 
 
Viral and bacterial clearance: On D+2 following the 
challenge, BHV-1 was detected in all calves. After D+6, 
the BHV-1 genomic quantity of the germanium biotite 
group decreased, showing a lower level than the control 
group (Fig. 2a). The viral genome load in trachea of the 
germanium biotite group was lower than the control group 
at post-mortem, while higher level than in the control 
group was observed in lungs of the germanium biotite 
group (Fig. 2c). Mannheimia haemolytica serotype A1 
was detected on D+2 by multiplex PCR in all calves 
except for two of the germanium biotite group (Fig. 3). 
Infection of two calves in the control group and one calf 
in the germanium biotite group was confirmed until 
D+10.  Mannheimia haemolytica serotype A1 was 
identified in lungs from a calf of the control group at post-
mortem, but not identified in other calves. The numbers of 
total bacteria isolated from nasal discharge in the 
germanium biotite and control groups showed no 
significant differences, but higher AUC than in the 
germanium biotite group was observed in the control 
group. The AUC of control and germanium biotite groups 
was 41.3±0.5 and 38.3±0.7, respectively (Fig. 2b). 
 
 
 
Fig. 1: Cumulative total clinical score was calculated from each clinical 
sign. The control group showed higher level than the germanium biotite 
group. 
 
Gross pathology and histopathologic analysis: Lung 
lesions of calves varied from brown to purple dark pink 
often associated with congestion and most of the lesions 
were present in apical lobes. The germanium biotite group 
showed lower distribution of surface lesions and their 
severity as compared to the control group. Compared with 
the control group, low hepatization of lung was confirmed 
in the germanium biotite group by palpation. Calves in the 
germanium biotite group showed a significant decrease in 
the percentages of superficial lesion area compared with 
the control group (P<0.01). The percentages of lesion area  
in the control and germanium biotite groups were 
34.8%±4.6 and 10.2%±3.0, respectively (Fig. 2d). In 
microscopic lung lesions, type 2 pneumocyte hypertrophy 
and hyperplasia, alveolar wall thickening, and neutrophils 
filtration were observed in all lungs of challenged calves, 
showing moderate signs in the germanium biotite group 
(Fig. 4). The microscopic lesion score of the germaniumPak Vet J, 2012, 32(3): 319-324. 
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Fig. 2: Clearance of challenge pathogens and percentage of lesion area. (a) Clearance of BHV-1 in experimentally infected calves. (b) Clearance of 
total bacteria in experimentally infected calves. The higher AUC than in the germanium biotite group was observed in the control group. (c) Quantity 
of BHV-1 genomes in trachea and lung at post-mortem. While germanium biotite group showed higher quantity of BHV-1 genomes than control 
group in lung, a lower quantity than in the control group was observed in trachea of germanium biotite group. Mannheimia haemolytica serotype A1 
was not detected at post-mortem, except for in a lung from a calf in the control group. (d) Percentages of superficial lesion area in experimentally 
infected calves. The germanium biotite group showed significantly lower percentages of lesion area than the control group. **Highly significant at 
P<0.01. 
 
Table 3: Microscopic lesion scores in challenged calves 
Groups Control  Germanium  biotite 
Scores (± SD)  5.00 (± 0.26) 
4.30 (± 0.34) 
4.36 (± 0.28) 
2.50 (± 0.23) 
1.75 (± 0.30) 
1.92 (± 0.38) 
Means (± SD)  4.55 (± 0.22)    2.06 (± 0.23) ** 
The microscopic lesion scores were calculated using a previous scoring 
system (Opriessnig et al., 2004). The control group shows higher lesion 
scores than the germanium biotite group significantly (P<0.01).  
 
biotite group (2.06±0.23) was significantly lower, 
compared with the control group (4.55±0.22) (Table 3). 
 
DISCUSSION 
 
BRD, along with diarrhea a major cause of calf 
deaths, is caused by multi-factors mainly immune 
depression. BHV-1 and Mannheimia haemolytica 
serotype A1 are usually isolated from calves suffering 
from BRD (Irsik et al., 2006; Fulton, 2009). In the cattle 
industry, antibiotics have been used as a feed supplement 
to prevent both BRD and secondary infections. Virus 
infection, however, cannot be prevented by using 
antibiotics, and the use of antibiotics has been gradually 
limited because of antibiotic residues and emergence of 
antibiotic resistance. In addition, there are restrictions on 
vaccination against viruses especially, live vaccines, in 
view of vaccine infection, latent infection, pathogen 
carrier and serological differentiation from wild infection 
(Bosch et al., 1996). For these reasons, activation of non-
specific immunity has been considered for controlling 
BRD in place of antibiotics. 
Silicate, the major constituent of germanium biotite, 
has been studied for its non-specific immune enhancing 
effects.  It   was   reported   that   macrophages   could   be 
 
 
Fig. 3: The confirmation of Mannheimia haemolytica serotype A1 
infection of claves on D+2 using multiplex PCR. Lines PC and NC, 
Postive control and negative control, respectively, lines 1-3; calves in 
control group and lines 4-6; calves in germanium biotite administrated 
group. PCR amplification regions of 304-bp, 206-bp, and 90-bp account 
for 16S rDNA gene, leukotoxin gene, and unknown hypothetical 
protein of Mannheimia haemolytica serotype A1. Mannheimia haemolytica 
serotype A1 is detected in all calves of the control group (1-3) and one 
calf of the germanium biotite group (4-6). 
 
stimulated and release large amounts of TNF-α by silicate 
in vitro (Holian et al., 1997). It was also reported that 
relative mRNA expression levels of IFN-γ, IL-4 and TNF-
α produced mainly by T cell and macrophages could 
increase significantly in splenocytes of aluminosilicate 
(Al2SiO5) orally primed mice. In addition, aluminosilicate 
(Al2SiO5) primed mice also showed high antibody 
production levels when they were exposed to formalin-
killed  Pasteurella multocida type A antigen. Moreover, 
oral ingestion of aluminosilicate (Al2SiO5) showed 
enhancing effects on reinforcing clearance of porcine 
circovirus type 2 in experimentally infected pigs (Jung et 
al., 2010). The results of these studies of immune 
activities of silicate make us postulate that germaniumPak Vet J, 2012, 32(3): 319-324. 
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Fig. 4: Histopathological features of lung tissue samples in challenged calves. Severe neutrophils filtration and thickened alveolar septa are observed 
in lungs of the control group (arrows in a and c) compared with the germanium biotite group (arrows in b and d). Bronchiole of the control group 
also contains more numerous neutrophils (arrowhead in e) compared with the germanium biotite group (arrowhead in f). 
 
biotite could have prophylactic effects on BRD occurred 
mainly with relevance to immunosuppression. However, a 
natural mineral like germanium biotite has not been 
studied for its prophylactic effect against BRD. In this 
study, the first analysis of the prophylactic effect of 
germanium biotite against BRD in experimentally 
infected calves was conducted. 
To investigate exact clinical signs, the normal 
temperature limit (39-40°C) confirmed in a previous study 
(Hodgson et al., 1995) was modified because situations in 
the present experiment, like rearing environments and 
breed of calves, differed from those in the previous study. 
Based on this information, the normal temperature limit 
was modified in the present experiment according to the 
mean of temperatures measured in preinoculated calves.  
Following the challenge, the germanium biotite group 
showed alleviated clinical signs compared with the control 
group. In accordance with these clinical results, the 
germanium biotite  group  showed  enhanced  clearance of 
BHV-1 and a low infection rate of Mannheimia 
haemolytica serotype A1 compared with the control 
group. The germanium biotite group also showed lower 
AUC of clearance of total bacteria in nasal swab samples. 
At post-mortem, however, the germanium biotite group 
showed a higher quantity of BHV-1 in lungs than the 
control group and a lower quantity in trachea than the 
control group. It appeared that there was a greater amount 
of virus shedding in the trachea in the control group, even 
though a high quantity of BHV-1 was detected in lungs of 
the germanium biotite group compared with the control 
group. Moreover, it was reported that severe clinical signs 
were usually accompanied by a high titer of virus 
shedding (Song et al., 2011). These clinical and clearance 
results correspond with superficial lesion area data and 
microscopic lesion analysis in the present study. 
Significantly higher percentages of normal area than the 
control group were observed in the germanium biotite 
group (P<0.01). In microscopic lung lesions, the 
germanium biotite group showed moderate signs of 
neutrophils filtration and bronchiolar exudates compared 
with the control group. Neutrophils filtration in alveoli and 
bronchial exudates are typical signs of bronchopneumonias, 
which are generally caused by bacteria. Therefore, it could 
be inferred that germanium biotite primed calves were 
protected from secondary infections caused mainly by 
bacteria like Mannheimia haemolytica serotype A1. 
 These results suggested that ingestion of germanium 
biotite had prophylactic effects against BHV-1 and 
Mannheimia haemolytica serotype A1 in calves. It can be 
presumed that the prophylactic effects of germanium Pak Vet J, 2012, 32(3): 319-324. 
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biotite against challenged BRD pathogens are associated 
with its stimulating activities on non-specific immune 
response. In conclusion, results of this study indicated that 
germanium biotite has the potential to activate innate 
immunity thereby could be a good alternative to 
antibiotics as a feed supplement for calves. Future 
research is needed focusing on the mechanism of 
absorption of germanium biotite in calves’ gastrointestinal 
tracts and the mechanism of non-specific immune 
stimulating effects. 
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